Abcam Investor Relations Material
Latest events
H2 2022
Abcam
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Abcam plc
Access all reports
Abcam plc is a global provider of life science research tools, specializing in the development and marketing of reagents and tools essential for research in the life sciences sector. The company's extensive product range includes primary and secondary antibodies, immunoassay kits, cellular and biochemical assays, proteins and peptides, as well as products for cell and tissue imaging. Abcam serves a broad array of customers including researchers in academia, clinical labs, and pharmaceutical, biotech, and diagnostic companies. Abcam is headquartered in Cambridge, Cambridgeshire, UK, and its shares are listed on the Nasdaq.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
ABCM
Country
🇺🇸 United States